Concepedia

Shuwen Cheng

SC

Statistics

Publications

6

Citations

129

H-Index

6

Active since

2021

Affiliations

Nanjing University(Current)

Zhongda Hospital Southeast University

Nanjing Medical University

Guizhou University

Shanxi Academy of Building Research

Shuwen Cheng is an author at Nanjing University specializing in oncology, medicine, and post-translational modification sites.

ORCID

Publications per year

2021–2025

6

Publications

6

Epitranscriptic regulation of <i>HRAS</i> by <i>N</i> <sup>6</sup> -methyladenosine drives tumor progression

Yongbo Pan, Yinmin Gu, Tihui Liu et al. · Proceedings of the National Academy of Sciences · 2023 · 30 citations · Full text

, , +17

Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells

Yibi Zhang, Xiaodong Wang, Yinmin Gu et al. · Proceedings of the National Academy of Sciences · 2025 · 26 citations · Full text

, , +17

PD-L2 of tumor-derived exosomes mediates the immune escape of cancer cells via the impaired T cell function

Tongfeng Liu, Shuwen Cheng, Bo Peng et al. · Cell Death and Disease · 2024 · 24 citations · Full text

, , +17

A splicing isoform of PD-1 promotes tumor progression as a potential immune checkpoint

Xuetong Wang, Tongfeng Liu, Yifei Li et al. · Nature Communications · 2024 · 21 citations · Full text

, , +17

DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression

Ya Wen, Xiwang Yang, Yifei Li et al. · Oncogene · 2024 · 15 citations

, , +7

1–5 of 6